Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Dec. 31, 2013	Mar. 18, 2014	Jun. 30, 2013
Document And Entity Information
Entity Registrant Name	MamaMancini's Holdings, Inc.
Entity Central Index Key	0001520358
Document Type	10-K
Document Period End Date	Dec. 31, 2013
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 12,524,616
Entity Common Stock, Shares Outstanding		25,257,374
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2013

Consolidated Balance Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Assets:
Cash	$ 1,741,935	$ 2,008,161
Accounts receivable, net	1,063,849	463,565
Inventories	112,279	76,570
Prepaid expenses	135,525	64,178
Due from manufacturer - related party	781,521	159,200
Deposit with manufacturer - related party	359,506	192,956
Total current assets	4,194,615	2,964,630
Property and equipment, net	929,496	17,451
Total Assets	5,124,111	2,982,081
Liabilities:
Accounts payable and accrued expenses	823,044	329,233
Line of credit		200,000
Total current liabilities	823,044	529,233
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.00001 par value; 20,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.00001 par value; 250,000,000 shares authorized; 24,187,375 and 20,054,000 shares issued and outstanding, respectively	242	201
Additional paid in capital	10,600,461	5,804,680
Common stock subscribed; 533,333 shares	5
Accumulated deficit	(6,299,641)	(3,352,033)
Total Stockholders' Equity	4,301,067	2,452,848
Total Liabilities and Stockholders' Equity	$ 5,124,111	$ 2,982,081

Consolidated Balance Sheets (Parenthetical)

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	24,187,375	20,054,000
Common stock, shares outstanding	24,187,375	20,054,000
Common stock subscribed, shares	533,333

Consolidated Statements of Operations

Consolidated Statements of Operations (USD $)	12 Months Ended
Consolidated Statements of Operations (USD $)	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Sales - net of slotting fees and discounts	$ 8,741,621	$ 4,582,845
Cost of sales	6,190,595	3,230,589
Gross profit	2,551,026	1,352,256
Operating expenses
Research and development	19,408	68,372
General and administrative expenses	5,470,586	3,271,160
Total operating Expenses	5,489,994	3,339,532
Loss from operations	(2,938,968)	(1,987,276)
Other income (expenses)
Interest expense	(8,640)	(12,347)
Total other income (expense)	(8,640)	(12,347)
Net loss	$ (2,947,608)	$ (1,999,623)
Net loss per common share - basic and diluted	$ (0.13)	$ (0.12)
Weighted average common shares outstanding - basic and diluted	22,012,920	17,358,333

Consolidated Statement of Changes in Stockholders' Equity

Consolidated Statement of Changes in Stockholders' Equity (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Common Stock Subscribed [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2011	$ 150	$ 1,401,573		$ (1,352,410)	$ 49,313
Balance, shares at Dec. 31, 2011	15,000,000
Common stock issued for cash	51	5,053,949			5,054,000
Common stock issued for cash, shares	5,054,000				5,054,000
Warrants issued for services		438,122			438,122
Stock issuance costs		(1,088,964)			(1,088,964)
Net loss				(1,999,623)	(1,999,623)
Balance at Dec. 31, 2012	201	5,804,680		(3,352,033)	2,452,848
Balance, shares at Dec. 31, 2012	20,054,000
Common stock issued for cash	33	4,999,967			5,000,000
Common stock issued for cash, shares	3,333,375
Common stock subscribed , 533,333 shares		799,995	5		800,000
Recapitalization	8	(295,008)			(295,000)
Recapitalization, shares	800,000
Stock options issued for services		162,933			162,933
Warrants issued for services		731,894			731,894
Stock issuance costs		(1,604,000)			(1,604,000)
Net loss				(2,947,608)	(2,947,608)
Balance at Dec. 31, 2013	$ 242	$ 10,600,461	$ 5	$ (6,299,641)	$ 4,301,067
Balance, shares at Dec. 31, 2013	24,187,375

Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)

Consolidated Statement of Changes in Stockholders' Equity (Parenthetical)	Dec. 31, 2013	Dec. 31, 2012
Statement of Stockholders' Equity [Abstract]
Common stock subscribed, shares	533,333

Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
Consolidated Statements of Cash Flows (USD $)	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,947,608)	$ (1,999,623)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	33,891	12,564
Share-based compensation	162,933
Loss on disposition of fixed assets	15,343
(Increase) Decrease in:
Accounts receivable	(600,284)	117,914
Inventory	(35,709)	24,540
Prepaid expenses	(71,347)	23,492
Due from manufacturer - related party	(622,321)	(159,200)
Deposit with manufacturer - related party	(166,550)	(90,096)
Increase (Decrease) in:
Accounts payable and accrued expenses	410,054	46,739
Due to manufacturer - related party		(69,544)
Net Cash Used In Operating Activities	(3,821,598)	(2,093,214)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for machinery and equipment	(877,522)	(10,000)
Deposits on property and equipment		(8,288)
Cash paid for acquisition of shell company	(295,000)
Loans to related party	(30,000)
Related party loans repaid	30,000
Net Cash Used In Investing Activities	(1,172,522)	(18,288)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	5,000,000	5,054,000
Stock issuance costs	(872,106)	(650,842)
Proceeds from common stock subscribed	800,000
Proceeds from credit line	150,000
Repayment of credit line	(350,000)	(300,000)
Net Cash Provided By Financing Activities	4,727,894	4,103,158
Net Increase (Decrease) in Cash	(266,226)	1,991,656
Cash - Beginning of Period	2,008,161	16,505
Cash - End of Period	1,741,935	2,008,161
Cash Paid During the Period for:
Income taxes
Interest	8,640	12,347
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING
Stock issuance costs paid in the form of warrants	731,894	438,122
Machinery and equipment purchased on account	$ 83,757

Nature of Operations and Basis of Presentation

12 Months Ended

Dec. 31, 2013

Nature Of Operations And Basis Of Presentation

Nature of Operations and Basis of Presentation

Note 1 - Nature of Operations and Basis of Presentation

Nature of Operations

MamaMancini’s Holdings, Inc. (the “Company”), (formerly known as Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation.

Current Business of the Company

The Company is a manufacturer and distributor of a line of beef meatballs with sauce, turkey meatballs with sauce, Italian sausage with sauce and other similar Italian meats with sauces. The Company’s customers are located throughout the United States, with a large concentration in the Northeastern and Southeastern United States regions.

Mergers

On January 24, 2013, the Company, Mascot Properties Acquisition Corp, a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), MamaMancini’s, Inc., a privately-held Delaware Corporation headquartered in New Jersey (“MamaMancini’s”) and an individual (the “Majority Shareholder”), entered into an Acquisition Agreement and Plan of Merger (the “Agreement”) pursuant to which the Merger Sub was merged with and into MamaMancini’s, with MamaMancini’s surviving as a wholly-owned subsidiary of the Company (the “Merger”). The Company acquired, through a reverse triangular merger, all of the outstanding capital stock of MamaMancini’s in exchange for issuing MamaMancini’s shareholders (the “MamaMancini’s Shareholders”), pro-rata, a total of 20,054,000 shares of the Company’s common stock. Immediately after the Merger was consummated, and further to the Agreement, the majority shareholders and certain affiliates of the Company cancelled a total of 103,408,000 shares of the Company’s common stock held by them (the “Cancellation”). In consideration of the Cancellation of such common stock, the Company paid the Majority Shareholder in aggregate of $295,000 and 800,000 shares of common stock and released the other affiliates from certain liabilities. In addition, the Company has agreed to spin out to the Majority Shareholder all assets related to the Company’s real estate management business within 30 days after the closing. As a result of the Merger and the Cancellation, the MamaMancini’s Shareholders became the majority shareholders of the Company.

The consolidated financial statements presented for all periods through and including December 31, 2013 are those of MamaMancini’s. As a result of this Merger, the equity sections of MamaMancini’s for all prior periods presented reflect the recapitalization described above and are consistent with the December 31, 2013 balance sheet presented for the Company.

Since the transaction is considered a reverse acquisition and recapitalization, the presentation of pro-forma financial information was not required.

Basis of Presentation

The consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

Principles of consolidation

All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for bad debt, inventory obsolescence, the fair value of share-based payments.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

Risks and uncertainties

The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.

The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

Cash

The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at December 31, 2013 and December 31, 2012.

The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.

Accounts receivable and allowance for doubtful accounts

Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of December 31, 2013 and 2012, the Company had reserves of $2,000.

Inventories

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at December 31, 2013 and 2012:

	December 31, 2013		December 31, 2012
Finished goods	$	112,279	$	76,570

Property and Equipment

Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives.

Asset lives for financial statement reporting of depreciation are:

Machinery and equipment	2-7 years
Vehicles	3-5 years

Fair Value of Financial Instruments

For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short term financial instruments approximates fair value due to the relatively short period to maturity for these instruments.

Stock Issuance Costs

Stock Issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity. Offering costs recorded to equity for the years ended December 31, 2013 and 2012 were$1,604,000 and $1,088,964, respectively.

Research and Development

Research and development is expensed as incurred. Research and development expenses for the years ended December 31, 2013 and 2012 were$19,408 and $68,372, respectively.

Shipping and Handling Costs

The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales.

Revenue Recognition

The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products.

The Company meets these criteria upon shipment.

Expenses such as slotting fees and sales discounts are accounted for as a direct reduction of revenues as follows:

	Year		Year
	Ended		Ended
	December 31, 2013		December 31, 2012
Gross Sales	$	9,282,562	$	4,948,254
Less: Slotting, Discounts, Allowances		540,941		365,409
Net Sales	$	8,741,621	$	4,582,845

Cost of sales

Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.

Advertising

Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the years ended December 31, 2013 and 2012 were$2,440,424 and $1,460,000, respectively.

Stock-based compensation

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock-Based Compensation” (“ASC 718”) which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation cost for stock option plans in accordance with ASC 718. The Company accounts for share based payments to non-employees in accordance with ASC 505-50 “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling Goods or Services”.

The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest.

Share based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the Statement of Operations. For the years ended December 31, 2013 and 2012 share based compensation amounted to $894,827 and $438,122, respectively.$731,894 of the $894,827 recorded for the year ended December 31, 2013 was a direct cost of a stock offering and has been recorded as a reduction in additional paid in capital. The $438,122 recorded for the year ended December 31, 2012 was a direct cost of a stock offering and has been recorded as a reduction in additional paid in capital.

For the year ended December 31, 2013, when computing fair value of share based payments, the Company has considered the following variables:

●	The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.68%-1.71%.

●	The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0.

●	The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

●	The expected warrant term is the life of the warrant.

●	The expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 144%-193%.

●	The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%.

	For the year ended December 31, 2012, when computing fair value of share based payments, the Company has considered the following variables:

●	The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.61%-1.01%.

●	The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0.

●	The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110.The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

●	The expected warrant term is the life of the warrant.

●	Given the Company was privately held, expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 128%-147%.

●	The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%.

Earnings per share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period.

The Company had the following potential common stock equivalents at December 31, 2013:

Common stock subscribed			533,333
Common stock warrants, exercise price range of $1.00-$1.50			892,067
Common stock options, exercise price of$1.00			428,845
Total common stock equivalents			1,854,245

The Company had the following potential common stock equivalents at December 31, 2012:

Common stock warrants, exercise price of $1.00			505,400
Common stock options, exercise price of $1.00			223,404
Total common stock equivalents			728,804

Since the Company reflected a net loss during the years ended December 31, 2013 and 2012, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented.

Income Taxes

Income taxes are provided in accordance with ASC No. 740, Accounting for Income Taxes. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the period of deferred tax assets and liabilities.

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Recent accounting pronouncements

There are no recent accounting pronouncements that are expected to have an effect on the Company’s financial statements.

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References+ Details

Property and Equipment

12 Months Ended

Dec. 31, 2013

Property, Plant and Equipment [Abstract]

Property and Equipment

Note 3 - Property and Equipment:

Property and equipment on December 31, 2013 and 2012 are as follows:

	December 31, 2013		December 31, 2012
Machinery and Equipment	$	982,017	$	39,627
		982,017		39,627
Less: Accumulated Depreciation		52,521		22,176
	$	929,496	$	17,451

At December 31, 2013 machinery and equipment in the amount of $826,340 was not in service.

Depreciation expense charged to income for the years ended December 31, 2013 and 2012 amounted to $33,891 and $12,564 respectively.

During the year ended December 31, 2013, a vehicle with an original cost of $18,889 and adjusted basis of $15,343 was raffled off during a marketing & promotion campaign.

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References+ Details

Credit Line

12 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

Credit Line

Note 4 - Credit Line

On October 13, 2010 the Company signed a revolving note (the “Note”) with Provident Bank (the “Bank”) for $1,000,000. The available balance of this Note was reduced to $400,000 and extended to September 1, 2013. The outstanding balance accrues interest at a variable rate of 1.00% over the Wall Street Journal prime rate with a floor of 4.50% per annum. (Starting July 2013 the interest rate floor increased to 5%) Interest is payable monthly and the rate as of December 31, 2012 was 4.50%.

Advances are limited to 80% of eligible receivables (75 days from invoice) and 35% of finished goods inventory (Starting July 2013 advances are limited to 70% of eligible receivables). Inventory advances shall be capped at $250,000. Concentrations from any one customer exceeding 30% of total accounts receivable will be excluded from the borrowing base availability. The note is secured by accounts receivable, inventory, financial instruments, equipment, general intangibles and investment property and personal and unconditional guarantees of two of the shareholders of the Company.

The balance outstanding on the revolving note at December 31, 2013 and 2012 was $0 and $200,000, respectively. On September 9, 2013 the Note was repaid and cancelled.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details

Investment in LLC

12 Months Ended

Dec. 31, 2013

Investments in and Advances to Affiliates, Schedule of Investments [Abstract]

Investment in LLC

Note 5- Investment in LLC

During 2011 the Company acquired a 34.62% interest in Meatball Obsession, LLC (“MO”) for a total investment of $27,032. This investment is accounted for using the equity method of accounting. Accordingly, investments are recorded at acquisition cost plus the Company’s equity in the undistributed earnings or losses of the entity. At December 31, 2011 the investment was brought down to $0 due to losses incurred by MO.

During 2012 the Company’s ownership interest in MO fell to 28% due to dilution.

During 2013 the Company’s ownership interest in MO fell to 15.8% due to dilution.

During the years ending December 31, 2013 and 2012, sales to MO were $85,541 and $73,768, respectively. At December 31, 2013 and 2012 the accounts receivable balance from MO was $1,457 and $12,680, respectively.

During 2013, the Company loaned MO $30,000 for working capital purposes. The loan was non-interest bearing, unsecured and due on June 19, 2013. The loan was paid in full on July 8, 2013.

Summarized financial information for Meatball Obsession, LLC is as follows:

Balance Sheet Data

	December 31, 2013		December 31, 2012
Assets
Cash	$	50,371	$	117,777
Accounts receivable		7,895		5,234
Inventory		11,417		14,935
Property & equipment, net		165,398		75,861
Other assets		51,368		60,370
Total Assets	$	286,449	$	274,177

Liabilities and Members’ Equity
Accounts payable	$	21,139	$	25,731
Other current liabilities		28,480		8,354
Total Current Liabilities		49,619		34,085
Members’ Equity		236,830		240,092
Total Liabilities and Members’ Equity	$	286,449	$	274,177

Statement of Operations Data
	December 31, 2013			December 31, 2012
Revenues	$	566,354		$	315,493
Cost of goods sold		220,672			129,571
Expenses		794,648			534,961
Net operating loss		(448,966	)		(349,039	)
Other income (expenses)		(4,296	)		(1,988	)
Net loss	$	(453,262	)	$	(351,027	)

Related Party Transactions

12 Months Ended

Dec. 31, 2013

Related Party Transactions

Note 6 - Related Party Transactions

Supply Agreement

On March 1, 2010, the Company entered into a five year agreement with a Manufacturer (the “Manufacturer”) who is a related party. The Manufacturer is owned by the CEO and President of the Company. Under the terms of the agreement, the Company grants to the Manufacturer a revocable license to use the Company’s recipes, formulas, methods and ingredients for the preparation and production of Company’s products, for manufacturing the Company’s product and all future improvements, modifications, substitutions and replacements developed by the Company. The Manufacturer in turn grants the Company the exclusive right to purchase the product. Under the terms of the agreement the Manufacturer agrees to manufacture, package, and store the Company’s products and the Company has the right to purchase products from one or more other manufacturers, distributors or suppliers. The agreement contains a perpetual automatic renewal clause for a period of one year after the expiration of the initial term. During the renewal period either party may cancel the contract with written notice nine months prior to the termination date.

Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the Manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the Manufacturer for any labor costs incurred in repackaging. Per the agreement, all product delivery shipping costs are the expense of the Company.

During the years ended December 31, 2013 and 2012, the Company purchased substantially all of it’s inventory from the Manufacturer. At December 31, 2013 and December 31, 2012, the Company has a deposit on inventory in the amount of $359,506 and $192,956, respectfully, to this Manufacturer.

Due from Manufacturer – related party

During years ended December 31, 2013 and 2012,the Manufacturer received payments on behalf of the Company for the Company’s customer invoices and the Manufacturer incurred expenses on behalf of the Company for shared administrative expenses and salary expenses. In addition the Company made several unsecured loans to the Manufacturer during 2013. The loan to the Manufacturer is unsecured, does not bear interest and is due on demand. At December 31, 2013 and 2012 the amount due from the Manufacturer is as follows:

	December 31, 2013			December 31, 2012
Customer receipts collected by Manufacturer on behalf of Company	$	575,255		$	301,447
Loan to Manufacturer		450,000			-
Shared expenses paid by Manufacturer on behalf of the Company		(243,734	)		(142,247	)
Due from Manufacturer	$	781,521		$	159,200

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References+ Details

Concentrations

12 Months Ended

Dec. 31, 2013

Risks and Uncertainties [Abstract]

Concentrations

Note 7 - Concentrations

Revenues

For years ended December 31, 2013 and 2012, the Company had the following concentrations of revenues with customers:

Customer	December 31, 2013			December 31, 2012
A		14	%		15	%
B		18	%		11	%
C		17	%		35	%
D		14	%		2	%
E		9	%		14	%

Accounts Receivable

As of December 31, 2013 and 2012, the Company had the following concentrations of accounts receivable with customers:

Customer	December 31, 2013			December 31, 2012
A		14	%		13	%
B		16	%		30	%
C		23	%		20	%

Cost of Sales

For the years ended December 31, 2013 and 2012, the Company had the following concentrations of purchases from vendors:

Vendor	December 31, 2013			December 31, 2012
A (Related Party)		100	%		99	%

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References+ Details

Stockholders' Equity

12 Months Ended

Dec. 31, 2013

Equity [Abstract]

Stockholders' Equity

Note 8 - Stockholders’ Equity

(A) Common Stock Transactions

2012

The Company issued 5,054,000 shares for cash proceeds of $5,054,000 ($1.00/share).

2013

As a result of the reverse merger (see Note 1) the Company had a deemed issuance of 800,000 shares of common stock.

From July 1, 2013 through December 31, 2013, the Company issued 3,333,375 shares of common stock to investors in exchange for $5,000,000 in proceeds in connection with the private placement of the Company’s stock.

Common stock subscribed

In December 2013, the Company sold 533,333 shares of common stock to investors in exchange for $800,000 in proceeds in connection with the private placement of the Company’s stock. As of December 31, 2013 the shares had not been issued.

In connection with the 2013 private placement the Company incurred fees of $1,604,000 consisting of $872,106 in cash and 386,666 warrants with a fair value of $731,894.

(B) Options

The following is a summary of the Company’s option activity:

	Options		Weighted Average Exercise Price

Outstanding – January 01, 2012		-	$	-
Exercisable – January 01, 2012		-	$	-
Granted		223,404	$	1.00
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – December 31, 2012		223,404	$	1.00
Exercisable – December 31, 2012		223,404	$	1.00
Granted		318,000	$	1.00
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding December 31, 2013		541,404	$	1.00
Exercisable – December 31, 2013		428,845	$	1.00

Options Outstanding									Options Exercisable

Range of Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

$	1.00		541,404		3.85 years	$	1.00		428,845	$	1.00

At December 31, 2013 and December 31, 2012, the total intrinsic value of options outstanding and exercisable was $812,106 and $0, respectively.

As of December 31, 2013, the Company has $90,931 in stock based compensation related to stock options that is yet to be vested. The weighted average expensing period of the unvested options is .8 years.

(C) Warrants

The following is a summary of the Company’s warrant activity:

	Warrants		Weighted Average Exercise Price

Outstanding – January 01, 2012		-	$	-
Exercisable – January 01, 2012		-	$	-
Granted		505,400	$	1.00
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – December 31, 2012		505,400	$	1.00
Exercisable – December 31, 2012		505,400	$	1.00
Granted		386,667	$	1.50
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – December 31, 2013		892,067	$	1.22
Exercisable – December 31, 2013		892,067	$	1.22

	Warrants Outstanding								Warrants Exercisable

Range of Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

$	1.00-$1.50		892,067		4.04 years	$	1.22		892,067	$	1.22

At December 31, 2013 and December 31, 2012, the total intrinsic value of warrants outstanding and exercisable was $1,144,767 and $0, respectively.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

+ Details

Commitments and Contingencies

12 Months Ended

Dec. 31, 2013

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 9- Commitments and Contingencies

Litigations, Claims and Assessments

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results.

Licensing and Royalty Agreements

On March 1, 2010, the Company was assigned a Development and License agreement (“the Agreement”). Under the terms of the Agreement the Licensor shall develop for the Company a line of beef meatballs with sauce, Italian sausage with sauce and other similar Italian meats with sauces for commercial manufacture, distribution and sale (each a “Licensor Product” and collectively the “Licensor Products”). Licensor shall work with Licensee to develop Licensor Products that are acceptable to Licensee. Upon acceptance of a Licensor Product by Licensee, Licensor’s trade secret recipes, formulas methods and ingredients for the preparation and production of such Licensor Products (the “Recipes”) shall be subject to this Development and License Agreement.

The term of the Agreement (the “Term”) shall consist of the Exclusive Term and the Non-Exclusive Term. The 12-month period beginning on each January 1 and ending on each December 31 is referred to herein as an “Agreement Year.”

The Exclusive Term began on January 1, 2009 (the “Effective Date”) and ends on the 50th anniversary of the Effective Date, unless terminated or extended as provided herein. Licensor, at its option, may terminate the Exclusive Term by notice in writing to Licensee, delivered between the 60th and the 90th day following the end of any Agreement Year if, on or before the 60th day following the end of such Agreement Year, Licensee has not paid Licensor Royalties with respect to such Agreement Year at least equal to the minimum royalty (the “Minimum Royalty”) for such Agreement Year. Subject to the foregoing sentence, and provided Licensee has not breached this Agreement and failed to cure such breach in accordance herewith, Licensee may extend the Exclusive Term for an additional twenty five (25) years, by notice in writing to Licensor, delivered on or before the 50th anniversary of the Effective Date.

The Non-Exclusive Term begins upon expiration of the Exclusive Term and continues indefinitely thereafter, until terminated by Licensor due to a material breach hereof by Licensee that remains uncured after notice and opportunity to cure in accordance herewith, or until terminated by Licensee.

Either party may terminate this Agreement in the event that the other party materially breaches its obligations and fails to cure such material breach within sixty (60) days following written notice from the non-breaching party specifying the nature of the breach. The following termination rights are in addition to the termination rights provided elsewhere in the agreement

●

Termination by Licensee - Licensee shall have the right to terminate this Agreement at any time on sixty (60) days written notice to Licensor. In such event, all moneys paid to Licensor shall be deemed non-refundable.

Under the terms of the Agreement the Company is required to pay quarterly royalty fees as follows:

During the Exclusive Term and the Non-Exclusive Term the Company will pay a royalty equal to the royalty rate (the “Royalty Rate”), multiplied by Company’s “Net Sales”. As used herein, “Net Sales” means gross invoiced sales of Products, directly or indirectly to unrelated third parties, less (a) discounts (including cash discounts), and retroactive price reductions or allowances actually allowed or granted from the billed amount (collectively “Discounts”); (b) credits, rebates, and allowances actually granted upon claims, rejections or returns, including recalls (voluntary or otherwise) (collectively, “Credits”); (c) freight, postage, shipping and insurance charges; (d) taxes, duties or other governmental charges levied on or measured by the billing amount, when included in billing, as adjusted for rebates and refunds; and (e) provisions for uncollectible accounts determined in accordance with reasonable accounting methods, consistently applied.

The Royalty Rate shall be: 6% of net sales up to $500,000 of net sales for each Agreement year; 4% of Net Sales from $500,000 up to $2,500,000 of Net Sales for each Agreement year; 2% of Net Sales from $2,500,000 up to $20,000,000 of Net Sales for each Agreement year; and 1% of Net Sales in excess of $20,000,000 of Net Sales for each Agreement year.

In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows:

Agreement Year	Minimum Royalty to be Paid with Respect to Such Agreement Year
1^st and 2^nd	$	-
3^rd and 4^th	$	50,000
5^th, 6^th and 7^th	$	75,000
8^th and 9^th	$	100,000
10^th and thereafter	$	125,000

The Company incurred $203,031 and $134,121 of royalty expenses for the years ended December 31, 2013 and 2012, respectively. Royalty expenses are included in general and administrative expenses on the Statement of Operations.

Agreements with Placement Agents and Finders

(A) December 1, 2011

The Company entered into a Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective December 1, 2011 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $6 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

Along with the above fees, the Company shall pay up to $40,000 for expenses incurred by Spartan in connection with this Financing, together with cost of background checks on the officers and directors of the Company.

During the year ended 2012 the Company paid to Spartan fees of $505,400 and issued Spartan 505,400 five year warrants with an exercise price of $1.00.

(B) May 2, 2013

The Company entered into a second Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective May 2, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and up to 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0mil-$5.0mil) outlined in the Spartan Advisory Agreement. On October 29, 2013 the Company entered into an amendment to the Agreement and the $10,000 monthly fee was cancelled.

During the year ended December 31, 2013 the Company paid to Spartan fees of $650,000 and issued Spartan 333,333 five year warrants with an exercise price of $1.50.

The Company entered into a third Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective October 22, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act, for a minimum of twenty-four months from the date of the agreement, as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $2.5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

The Company shall pay to Spartan a non-refundable monthly fee of $10,000 for the term of the agreement. Such monthly fee shall survive any termination of the Agreement.

During the year ended December 31, 2013 the Company paid to Spartan financing fees of $104,000 and issued Spartan 53,333 five year warrants with an exercise price of $1.50.

Supply Agreement

On October 3, 2011, the Company entered into a five year agreement with a non-related party manufacturer. Under the terms of the agreement, the Company grants to the manufacturer a revocable license to use the Company’s recipes, formulas, methods and ingredients for the preparation and production of Company’s products, for manufacturing the Company’s product and all future improvements, modifications, substitutions and replacements developed by the Company. The manufacturer in turn grants the Company the exclusive right to purchase the product. Under the terms of the agreement the manufacturer agrees to manufacture, package, and store the Company’s products and the Company has the right to purchase products from one or more other manufacturers, distributors or suppliers. The agreement contains a perpetual automatic renewal clause for additional periods of one year after the expiration of the initial term. During the renewal periods either party may cancel the contract with written notice nine months prior to the termination date.

Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the manufacturer for any labor costs incurred in repackaging. Per the agreement all product delivery shipping costs are the expense of the Company.

Under the terms of the agreement, the Company is required to acquire and install production equipment at the manufacturer’s facility to be used solely for the manufacturing of the Company’s products. The manufacturer will bear all costs of operating and maintaining the production equipment during the period in which the manufacturer is manufacturing products pursuant to the agreement. The production equipment shall be owned by the Company.

In March 2012, the agreement was terminated and production equipment held by the manufacturer was returned to the Company.

- Definition

The entire disclosure for commitments and contingencies.

+ References+ Details

Income Tax Provision (Benefit)

12 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Income Tax Provision (Benefit)

Note 10 - Income Tax Provision (Benefit)

The income tax provision (benefit) consists of the following:

	December 31, 2013			December 31, 2012
Federal
Current	$	-		$	-
Deferred		(945,289	)		(599,149	)
State and Local
Current		-			-
Deferred		(361,363	)		-
Change in valuation allowance		1,306,652			599,149
Income tax provision (benefit)	$	-		$	-

The Company has U.S. federal net operating loss carryovers (NOLs) of approximately $4.6M and $1.6M at December 31, 2013 and 2012, respectively, available to offset taxable income through 2033. If not used, these NOLs may be subject to limitation under Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under the regulations. The Company plans on undertaking a detailed analysis of any historical and/or current Section 382 ownership changes that may limit the utilization of the net operating loss carryovers. The Company also has New Jersey State Net Operating Loss carry overs of $4.6M and $1.6M, as of December 31, 2013 and 2012, respectively, available to offset future taxable income through 2033.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon future generation for taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all the information available, Management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2013 and 2012, the change in the valuation allowance was $1,306,652 and $599,149.

The Company evaluated the provisions of ASC 740 related to the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740 prescribes a comprehensive model for how a company should recognize, present, and disclose uncertain positions that the Company has taken or expects to take in its tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the net benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits.” A liability is recognized (or amount of net operating loss carry forward or amount of tax refundable is reduced) for unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740.

If applicable, interest costs related to the unrecognized tax benefits are required to be calculated and would be classified as “Other expenses – Interest” in the statement of operations. Penalties would be recognized as a component of “General and administrative.”

No interest or penalties on unpaid tax were recorded during the years ended December 31, 2013 and 2012, respectively. As of December 31, 2013 and 2012, no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next year.

The Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following:

	Years Ended
Deferred Tax Assets	December 31, 2013			December 31, 2012

Net operating loss carryovers	$	1,939,069		$	599,149

Total deferred tax assets	$	1,939,069		$	599,149
Valuation allowance		(1,905,801	)		(599,149	)
Deferred tax asset, net of valuation allowance	$	33,268		$	-

Deferred Tax Liabilities

Other deferred tax liabilities		(33,268	)		-
Total deferred tax liabilities	$	(33,268	)	$	-
Net deferred tax asset (liability)	$	-		$	-

The expected tax expense (benefit) based on the statutory rate is reconciled with actual tax expense benefit as follows:

	Year ended December 31, 2013			Year ended December 31, 2012

US Federal statutory rate		(34.00	)%		(34.00	)%
State income tax, net of federal benefit		(5.9	)		(5.9	)
Deferred tax true-up		(6.8	)		-
Change in valuation allowance		44.3			36.7
Other permanent differences		2.4			3.2
Income tax provision (benefit)		- %			- %

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References+ Details

Subsequent Events

12 Months Ended

Dec. 31, 2013

Subsequent Events [Abstract]

Subsequent Events

Note 11 - Subsequent Events

The Company has evaluated all events that occurred after the balance sheet date through the date when the consolidated financial statements were issued to determine if they must be reported. The Management of the Company determined that there were certain reportable subsequent events to be disclosed as follow.

Entry Into A Material Definitive Agreement

Effective January 3, 2014, MamaMancini’s Inc. (“Mama’s”) a Delaware corporation and wholly owned subsidiary of MamaMancini’s Holdings, Inc. (the “Company”), entered into a Sale and Security Agreement (the “Sale and Security Agreement”) with Faunus Group International, Inc. (“FGI”) to provide for a $1.5 million secured demand credit facility backed by its receivables and inventory (the “FGI Facility”). The Sale and Security Agreement has an initial three (3) year term (the “Original Term”) and shall be extended automatically for an additional one (1) year for each succeeding term unless written notice of termination is given by either party at least sixty (60) days prior to the end of the Original Term or any extension thereof. The Company and certain of its affiliates also entered into guarantees to guarantee the performance of the obligations under the Sale and Security Agreement (the “Guaranty Agreements”). Mama’s also granted FGI a security interest in and lien upon all of Mama’s right, title and interest in and to all of Mama’s Collateral (as defined in the Sale and Security Agreement).

Pursuant to the FGI Facility, FGI can elect to purchase eligible accounts receivables (“Purchased Accounts”) up to 70% of the value of such receivables (retaining a 30% reserve). At FGI’s election, FGI may advance Mama’s up to 70% of the value of any Purchased Accounts, subject to the FGI Facility. Reserves retained by FGI on any Purchased Accounts are expected to be refunded to Mama’s net of interest and fees on advances once the receivables are collected from customers. The interest rate on advances or borrowings under the FGI Facility will be the greater of (i) 6.75% per annum and (ii) 2.50% above the rate of interest designated by FGI as its selected “Prime Rate” or “Base Rate’, as the case may be (which as of the date hereof is based upon the Wall Street Journal, Money Rates Section). Any advances or borrowings under the FGI Facility are due on demand.

Mama’s also agreed to pay to FGI monthly collateral management fees of 0.42% of the average monthly balance of Purchased Accounts. The minimum monthly net funds employed during each contract year hereof shall be $500,000. Additionally, Mama’s paid FGI a one-time facility fee equal to 1% of the FGI Facility upon entry into the Sale and Security Agreement.

For further details please see the 8-K filed by the Company on January 10, 2014.

Change of year end

Effective January 13, 2014, MamaMancini’s Holdings, Inc. (the “Company”) changed its fiscal year-end date to January 31. The Company’s 2014 fiscal year shall commence on February 1, 2014 and conclude on January 31, 2015. The Company will file an Annual Report on Form 10-K for the year ended December 31, 2013 and will also file a transitional report with the United States Securities and Exchange Commission for the period of January 1, 2014 to January 31, 2014.

Unregistered Sale of Equity Securities

From January 1, 2014 through March 14, 2014, the Company issued 536,667 shares of common stock to investors in exchange for $805,000 in proceeds in connection with the private placement of the Company’s stock. The Company incurred approximately $104,650 in stock issuance costs in conjunction with the placement and issued Spartan 53,667 five year warrants with an exercise price of $1.50.

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Principles of Consolidation

Principles of consolidation

All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

Use of estimates

Risks and Uncertainties

Risks and uncertainties

Cash

Cash

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable and allowance for doubtful accounts

Inventories

Inventories

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at December 31, 2013 and 2012:

		December 31, 2013				December 31, 2012
Finished goods		$	112,279			$	76,570

Property and Equipment

Property and Equipment

Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives.

Asset lives for financial statement reporting of depreciation are:

Machinery and equipment	2-7 years
Vehicles	3-5 years

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Stock Issuance Costs

Stock Issuance Costs

Research and Development

Research and Development

Research and development is expensed as incurred. Research and development expenses for the years ended December 31, 2013 and 2012 were$19,408 and $68,372, respectively.

Shipping and Handling Costs

Shipping and Handling Costs

The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales.

Revenue Recognition

Revenue Recognition

The Company meets these criteria upon shipment.

Expenses such as slotting fees and sales discounts are accounted for as a direct reduction of revenues as follows:

	Year		Year
	Ended		Ended
	December 31, 2013		December 31, 2012
Gross Sales	$	9,282,562	$	4,948,254
Less: Slotting, Discounts, Allowances		540,941		365,409
Net Sales	$	8,741,621	$	4,582,845

Cost of Sales

Cost of sales

Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.

Advertising

Advertising

Stock-based Compensation

Stock-based compensation

For the year ended December 31, 2013, when computing fair value of share based payments, the Company has considered the following variables:

●	The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.68%-1.71%.

●	The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0.

●	The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

●	The expected warrant term is the life of the warrant.

●	The expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 144%-193%.

●	The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%.

	For the year ended December 31, 2012, when computing fair value of share based payments, the Company has considered the following variables:

●	The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.61%-1.01%.

●	The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was $0.

●	The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110.The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

●	The expected warrant term is the life of the warrant.

●	Given the Company was privately held, expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 128%-147%.

●	The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%.

Earnings Per Share

Earnings per share

The Company had the following potential common stock equivalents at December 31, 2013:

Common stock subscribed			533,333
Common stock warrants, exercise price range of $1.00-$1.50			892,067
Common stock options, exercise price of$1.00			428,845
Total common stock equivalents			1,854,245

The Company had the following potential common stock equivalents at December 31, 2012:

Common stock warrants, exercise price of $1.00			505,400
Common stock options, exercise price of $1.00			223,404
Total common stock equivalents			728,804

Income Taxes

Income Taxes

Recent Accounting Pronouncements

Recent accounting pronouncements

There are no recent accounting pronouncements that are expected to have an effect on the Company’s financial statements.

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2013

Accounting Policies [Abstract]

Schedule of Inventories

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at December 31, 2013 and 2012:

	December 31, 2013		December 31, 2012
Finished goods	$	112,279	$	76,570

Schedule of Property and Equipment Estimated Useful Lives

Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives.

Asset lives for financial statement reporting of depreciation are:

Machinery and equipment	2-7 years
Vehicles	3-5 years

Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction

Expenses such as slotting fees and sales discounts are accounted for as a direct reduction of revenues as follows:

	Year		Year
	Ended		Ended
	December 31, 2013		December 31, 2012
Gross Sales	$	9,282,562	$	4,948,254
Less: Slotting, Discounts, Allowances		540,941		365,409
Net Sales	$	8,741,621	$	4,582,845

Schedule of Common Stock Equivalents

The Company had the following potential common stock equivalents at December 31, 2013:

Common stock subscribed			533,333
Common stock warrants, exercise price range of $1.00-$1.50			892,067
Common stock options, exercise price of$1.00			428,845
Total common stock equivalents			1,854,245

The Company had the following potential common stock equivalents at December 31, 2012:

Common stock warrants, exercise price of $1.00			505,400
Common stock options, exercise price of $1.00			223,404
Total common stock equivalents			728,804

Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2013

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment

Property and equipment on December 31, 2013 and 2012 are as follows:

	December 31, 2013		December 31, 2012
Machinery and Equipment	$	982,017	$	39,627
		982,017		39,627
Less: Accumulated Depreciation		52,521		22,176
	$	929,496	$	17,451

Investment in LLC (Tables)

Investment in LLC (Tables) (Meatball Obsession, LLC [Member])

12 Months Ended

Dec. 31, 2013

Meatball Obsession, LLC [Member]

Summary of Financial Information

Summarized financial information for Meatball Obsession, LLC is as follows:

Balance Sheet Data

	December 31, 2013		December 31, 2012
Assets
Cash	$	50,371	$	117,777
Accounts receivable		7,895		5,234
Inventory		11,417		14,935
Property & equipment, net		165,398		75,861
Other assets		51,368		60,370
Total Assets	$	286,449	$	274,177

Liabilities and Members’ Equity
Accounts payable	$	21,139	$	25,731
Other current liabilities		28,480		8,354
Total Current Liabilities		49,619		34,085
Members’ Equity		236,830		240,092
Total Liabilities and Members’ Equity	$	286,449	$	274,177

Statement of Operations Data
	December 31, 2013			December 31, 2012
Revenues	$	566,354		$	315,493
Cost of goods sold		220,672			129,571
Expenses		794,648			534,961
Net operating loss		(448,966	)		(349,039	)
Other income (expenses)		(4,296	)		(1,988	)
Net loss	$	(453,262	)	$	(351,027	)

Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2013

Schedule of Amount Due from Manufacturer

At December 31, 2013 and 2012 the amount due from the Manufacturer is as follows:

	December 31, 2013			December 31, 2012
Customer receipts collected by Manufacturer on behalf of Company	$	575,255		$	301,447
Loan to Manufacturer		450,000			-
Shared expenses paid by Manufacturer on behalf of the Company		(243,734	)		(142,247	)
Due from Manufacturer	$	781,521		$	159,200

Concentrations (Tables)

12 Months Ended

Dec. 31, 2013

Risks and Uncertainties [Abstract]

Schedule of Revenue

For years ended December 31, 2013 and 2012, the Company had the following concentrations of revenues with customers:

Customer	December 31, 2013			December 31, 2012
A		14	%		15	%
B		18	%		11	%
C		17	%		35	%
D		14	%		2	%
E		9	%		14	%

Schedule of Accounts Receivable

As of December 31, 2013 and 2012, the Company had the following concentrations of accounts receivable with customers:

Customer	December 31, 2013			December 31, 2012
A		14	%		13	%
B		16	%		30	%
C		23	%		20	%

Schedule of Cost of Sales

For the years ended December 31, 2013 and 2012, the Company had the following concentrations of purchases from vendors:

Vendor	December 31, 2013			December 31, 2012
A (Related Party)		100	%		99	%

Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2013

Equity [Abstract]

Summary of Option Activity

The following is a summary of the Company’s option activity:

	Options		Weighted Average Exercise Price

Outstanding – January 01, 2012		-	$	-
Exercisable – January 01, 2012		-	$	-
Granted		223,404	$	1.00
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – December 31, 2012		223,404	$	1.00
Exercisable – December 31, 2012		223,404	$	1.00
Granted		318,000	$	1.00
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding December 31, 2013		541,404	$	1.00
Exercisable – December 31, 2013		428,845	$	1.00

Summary of Option Outstanding and Exercisable

Options Outstanding									Options Exercisable

Range of Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

$	1.00		541,404		3.85 years	$	1.00		428,845	$	1.00

Schedule of Warrants Activity

The following is a summary of the Company’s warrant activity:

	Warrants		Weighted Average Exercise Price

Outstanding – January 01, 2012		-	$	-
Exercisable – January 01, 2012		-	$	-
Granted		505,400	$	1.00
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – December 31, 2012		505,400	$	1.00
Exercisable – December 31, 2012		505,400	$	1.00
Granted		386,667	$	1.50
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – December 31, 2013		892,067	$	1.22
Exercisable – December 31, 2013		892,067	$	1.22

Schedule of Warrants Outstanding and Exercisable

	Warrants Outstanding								Warrants Exercisable

Range of Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

$	1.00-$1.50		892,067		4.04 years	$	1.22		892,067	$	1.22

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References+ Details

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2013

Commitments and Contingencies Disclosure [Abstract]

Schedule of Royalty Minimum Payment by Preceding Agreement Year

In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows:

Agreement Year	Minimum Royalty to be Paid with Respect to Such Agreement Year
1^st and 2^nd	$	-
3^rd and 4^th	$	50,000
5^th, 6^th and 7^th	$	75,000
8^th and 9^th	$	100,000
10^th and thereafter	$	125,000

Income Tax Provision (Benefit) (Tables)

12 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Scheudle of Provision For Income Tax

The income tax provision (benefit) consists of the following:

	December 31, 2013			December 31, 2012
Federal
Current	$	-		$	-
Deferred		(945,289	)		(599,149	)
State and Local
Current		-			-
Deferred		(361,363	)		-
Change in valuation allowance		1,306,652			599,149
Income tax provision (benefit)	$	-		$	-

Schedule of Deferred Tax Assets

The Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following:

	Years Ended
Deferred Tax Assets	December 31, 2013			December 31, 2012

Net operating loss carryovers	$	1,939,069		$	599,149

Total deferred tax assets	$	1,939,069		$	599,149
Valuation allowance		(1,905,801	)		(599,149	)
Deferred tax asset, net of valuation allowance	$	33,268		$	-

Deferred Tax Liabilities

Other deferred tax liabilities		(33,268	)		-
Total deferred tax liabilities	$	(33,268	)	$	-
Net deferred tax asset (liability)	$	-		$	-

Schedule of Reconciliation of Provision For Income Taxes

The expected tax expense (benefit) based on the statutory rate is reconciled with actual tax expense benefit as follows:

	Year ended December 31, 2013			Year ended December 31, 2012

US Federal statutory rate		(34.00	)%		(34.00	)%
State income tax, net of federal benefit		(5.9	)		(5.9	)
Deferred tax true-up		(6.8	)		-
Change in valuation allowance		44.3			36.7
Other permanent differences		2.4			3.2
Income tax provision (benefit)		- %			- %

Nature of Operations and Basis of Presentation (Details Narrative)

Nature of Operations and Basis of Presentation (Details Narrative) (USD $)	0 Months Ended
	Jan. 24, 2013
Nature Of Operations And Basis Of Presentation
Number of shares issued in exchange for acquisition	20,054,000
Number of shares cancelled	103,408,000
Aggregate amount paid in cancellation to majority shareholders	$ 295,000
Stock issued for consideration of common stock cancellation for majority shareholders	800,000

Summary of Significant Accounting Policies (Details Narrative)

Summary of Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Cash equivalents	$ 0	$ 0
Accounts receivable reserves	2,000	2,000
Stock offering cost recorded	1,604,000	1,088,964
Research and development expense	19,408	68,372
Advertising expenses	2,440,424	1,460,000
Share based compensation	894,827	438,122
Reduction in additional paid in capital	731,894	438,122
Assumption risk-free interest rate of option in effect at the time of the grant minimum	0.68%	0.61%
Assumption risk-free interest rate of option in effect at the time of the grant maximum	1.71%	1.01%
Expected common stock dividend rate	$ 0	$ 0
Expected volatility rate, minimum	144.00%	128.00%
Expected volatility rate, maximum	193.00%	147.00%
Historical forfeiture rate for unvested stock option	0.00%	0.00%

Summary of Significant Accounting Policies - Schedule of Inventories (Details)

Summary of Significant Accounting Policies - Schedule of Inventories (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Finished goods	$ 112,279	$ 76,570

Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details)

Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details)	12 Months Ended
	Dec. 31, 2013
Minimum [Member] \| Machinery And Equipment [Member]
Property and equipment estimated useful lives	2 years
Minimum [Member] \| Vehicles [Member]
Property and equipment estimated useful lives	3 years
Maximum [Member] \| Machinery And Equipment [Member]
Property and equipment estimated useful lives	7 years
Maximum [Member] \| Vehicles [Member]
Property and equipment estimated useful lives	5 years

Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction (Details)

Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Gross Sales	$ 9,282,562	$ 4,948,254
Less: Slotting, Discounts, Allowances	540,941	365,409
Net Sales	$ 8,741,621	$ 4,582,845

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details)	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Common stock subscribed, shares	533,333
Common stock warrants, exercise price of $1.00- $1.50	892,067	505,400
Common stock options, exercise price of $1.00	428,845	223,404
Total common stock equivalents	1,854,245	728,804

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) (Parenthetical)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Common stock warrants, exercise price range		$ 1.00
Common stock options, exercise price	$ 1.00	$ 1.00
Minimum [Member]
Common stock warrants, exercise price range	$ 1.00
Maximum [Member]
Common stock warrants, exercise price range	$ 1.50

Property and Equipment (Details Narrative)

Property and Equipment (Details Narrative) (USD $)	12 Months Ended
Property and Equipment (Details Narrative) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Machinery and equipment	$ 826,340
Depreciation expense	33,891	12,564
Vehicle original cost	982,017	39,627
Adjustment basis of marketing promotion campaign price	15,343
Vehicles [Member]
Vehicle original cost	$ 18,889

Property and Equipment - Schedule of Property Plant and Equipment (Details)

Property and Equipment - Schedule of Property Plant and Equipment (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Property, plant and equipment	$ 982,017	$ 39,627
Less: Accumulated Depreciation	52,521	22,176
Property, plant and equipment, net	929,496	17,451
Machinery And Equipment [Member]
Property, plant and equipment	$ 982,017	$ 39,627

Credit Line (Details Narrative)

Credit Line (Details Narrative) (USD $)	0 Months Ended	12 Months Ended
Credit Line (Details Narrative) (USD $)	Jul. 03, 2013	Dec. 31, 2013	Dec. 31, 2012	Oct. 13, 2010
Debt Disclosure [Abstract]
Maximum limit of the notes outstanding balance				$ 1,000,000
Note principal limited after reduction		400,000
Variable rate of accrued interest on the outstanding balance		1.00%
Line of credit facility, floor rate	5.00%	4.50%	4.50%
Monthly payable interest rate			4.50%
Percentage of eligible receivables for which advances are limited	70.00%	80.00%
Percentage of finished goods inventory for which advances are limited		35.00%
Maximum limit for inventory advances				250,000
Customers exceeding thirty percent of the accounts receivables excluded from borrowing capacity		30.00%
Line of credit, balance outstanding		$ 0	$ 200,000

Investment in LLC (Details Narrative)

Investment in LLC (Details Narrative) (USD $)	0 Months Ended		12 Months Ended
Investment in LLC (Details Narrative) (USD $)	Jul. 08, 2013	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012
Reduction in investment due to losses in affiliates		$ 0
Sales revenue			8,741,621	4,582,845
Repayment of debt	30,000
Meatball Obsession, LLC [Member]
Percentage of equity interest acquired in business combination		34.62%
Total investment in Meatball Obsession, LLC		27,032
Reduction in ownership percentage			15.80%	28.00%
Sales revenue			85,541	73,768
Accounts receivable			1,457	12,680
Loan to affiliates for working capital purpose			$ 30,000
Loan due date			Jun. 19, 2013

Summary of Financial Information (Details)

Summary of Financial Information (Details) (USD $)	12 Months Ended
Summary of Financial Information (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash	$ 1,741,935	$ 2,008,161	$ 16,505
Accounts receivable	1,063,849	463,565
Inventory	112,279	76,570
Property & equipment, net	929,496	17,451
Total Assets	5,124,111	2,982,081
Total Current Liabilities	823,044	529,233
Members' Equity	4,301,067	2,452,848	49,313
Total Liabilities and Members' Equity	5,124,111	2,982,081
Expenses	5,489,994	3,339,532
Net operating loss	(2,938,968)	(1,987,276)
Other income (expenses)	(8,640)	(12,347)
Net loss	(2,947,608)	(1,999,623)
Meatball Obsession, LLC [Member]
Cash	50,371	117,777
Accounts receivable	7,895	5,234
Inventory	11,417	14,935
Property & equipment, net	165,398	75,861
Other assets	51,368	60,370
Total Assets	286,449	274,177
Accounts payable	21,139	25,731
Other current liabilities	28,480	8,354
Total Current Liabilities	49,619	34,085
Members' Equity	236,830	240,092
Total Liabilities and Members' Equity	286,449	274,177
Revenues	556,354	315,493
Cost of goods sold	220,672	129,571
Expenses	794,648	534,961
Net operating loss	(448,966)	(349,039)
Other income (expenses)	(4,296)	(1,988)
Net loss	$ (453,262)	$ (351,027)

Related Party Transactions (Details Narrative)

Related Party Transactions (Details Narrative) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Related Party Transactions [Abstract]
Deposit in inventory with manufacturer	$ 359,506	$ 192,956

Related Party Transactions - Schedule of Amount Due from Manufacturer (Details)

Related Party Transactions - Schedule of Amount Due from Manufacturer (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Related Party Transactions [Abstract]
Customer receipts collected by Manufacturer on behalf of Company	$ 575,255	$ 301,447
Loan to Manufacturer	450,000
Shared expenses paid by Manufacturer on behalf of the Company	(243,734)	(142,247)
Due from Manufacturer	$ 781,521	$ 159,200

Concentrations - Schedule of Revenue (Details)

Concentrations - Schedule of Revenue (Details)	12 Months Ended
Concentrations - Schedule of Revenue (Details)	Dec. 31, 2013	Dec. 31, 2012
Customer A [Member]
Concentrations of Revenues	14.00%	15.00%
Customer B [Member]
Concentrations of Revenues	18.00%	11.00%
Customer C [Member]
Concentrations of Revenues	17.00%	35.00%
Customer D [Member]
Concentrations of Revenues	14.00%	2.00%
Customer E [Member]
Concentrations of Revenues	9.00%	14.00%

Concentrations - Schedule of Accounts Receivable (Details)

Concentrations - Schedule of Accounts Receivable (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Customer A [Member]
Concentration of Accounts Receivable	14.00%	13.00%
Customer B [Member]
Concentration of Accounts Receivable	16.00%	30.00%
Customer C [Member]
Concentration of Accounts Receivable	23.00%	20.00%

Concentrations - Schedule of Purchases From Major Vendors (Details)

Concentrations - Schedule of Purchases From Major Vendors (Details) (Vendor A [Member])	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Vendor A [Member]
A (Related Party)	100.00%	99.00%

Stockholders' Equity (Details Narrative)

Stockholders' Equity (Details Narrative) (USD $)	6 Months Ended	12 Months Ended
Stockholders' Equity (Details Narrative) (USD $)	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity [Abstract]
Proceeds from issuance of common stock		$ 5,000,000	$ 5,054,000
Common stock issued cash, shares			5,054,000
Stock options exercise price	$ 1.00	$ 1.00	$ 1.00
Issuance of common stock shares in reverse merger		800,000
Common stock shares issued in private placement	3,333,375
Proceed from common stock shares issued in private placement	5,000,000
Sold common shares		533,333
Common stock invetors in exchange		800,000
Stock issuance costs relating to private placement	1,604,000
Stock issuance consisting cash		872,106	650,842
Number of warrants issued		386,666
Warrants issued for services		731,894	438,122
Total intrinsic value of options outstanding and exercisable	812,106	812,106	0
Stock based compensation related to stock option	90,931	90,931
Weighted average expensing period		8 years
Total intrinsic value of warrants outstanding and exercisable	$ 1,144,767	$ 1,144,767	$ 0

Stockholders' Equity - Summary of Option Activity (Details)

Stockholders' Equity - Summary of Option Activity (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Equity [Abstract]
Options Outstanding, Beginning balance	223,404
Options, Granted	318,000	223,404
Options, Exercised
Options, Forfeited/Cancelled
Options Outstanding, Ending balance	541,404	223,404
Options Exercisable, Beginning balance	223,404
Options Exercisable, Ending balance	428,845	223,404
Options Outstanding, Weighted Average Exercise Price, Beginning balance	$ 1.00
Weighted Average Exercise Price, Granted	$ 1.00	$ 1.00
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited/Cancelled
Options Outstanding, Weighted Average Exercise Price, Ending balance	$ 1.00	$ 1.00
Options Exercisable, Weighted Average Exercise Price, Beginning balance	$ 1.00
Options Exercisable, Weighted Average Exercise Price, Ending balance	$ 1.00	$ 1.00

Stockholders' Equity - Summary of Option Outstanding and Exercisable (Details)

Stockholders' Equity - Summary of Option Outstanding and Exercisable (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity [Abstract]
Range of exercise price	$ 1.00
Number of Options Outstanding	541,404	223,404
Weighted Average Remaining Contractual Life (in years), Options Outstanding	3 years 10 months 6 days
Weighted Average Exercise Price, Options Outstanding	$ 1.00	$ 1.00
Number of Options Exercisable	428,845	223,404
Weighted Average Exercise Price, Options Exercisable	$ 1.00	$ 1.00

Stockholders' Equity - Schedule of Warrants Activity (Details)

Stockholders' Equity - Schedule of Warrants Activity (Details) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Warrant [Member]
Warrants Outstanding, Beginning balance	505,400
Warrants, Granted	386,667	505,400
Warrants, Exercised
Warrants, Forfeited/Cancelled
Warrants Outstanding, Ending balance	892,067	505,400
Warrants Exercisable, Begining balance	505,400
Warrants Exercisable, Ending balance	892,067	505,400
Warrants Outstanding, Weighted Average Exercise Price, Beginning balance	$ 1.00
Weighted Average Exercise Price, Granted	$ 1.50	$ 1.00
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited/Cancelled
Warrants Outstanding, Weighted Average Exercise Price, Ending balance	$ 1.22	$ 1.00
Warrants Exercisable, Weighted Average Exercise Price, Beginning balance	$ 1.00
Warrants Exercisable, Weighted Average Exercise Price, Ending balance	$ 1.22	$ 1.00

Schedule of Warrants Outstanding and Exercisable (Details)

Schedule of Warrants Outstanding and Exercisable (Details) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Warrant [Member]
Range of exercise price, lower limit	$ 1.00
Range of exercise price, higher limit	$ 1.50
Number of Warrants Outstanding	892,067
Weighted Average Remaining Contractual Life (in Years)	4 years 15 days
Weighted Average Exercise Price, Warrants Outstanding	$ 1.22
Number of Warrants Exercisable	892,067	505,400
Weighted Average Exercise Price, Warrants Exercisable	$ 1.22	$ 1.00

Commitments and Contingencies (Details Narrative)

Commitments and Contingencies (Details Narrative) (USD $)	6 Months Ended	12 Months Ended		0 Months Ended	12 Months Ended	0 Months Ended		12 Months Ended	0 Months Ended	12 Months Ended		12 Months Ended
	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 01, 2011 Advosory Agreement One [Member]	Dec. 31, 2012 Advosory Agreement One [Member] Spartan Capital Securities, LLC [Member]	May 02, 2013 Advosory Agreement Two [Member]	May 02, 2013 Advosory Agreement Two [Member]	Dec. 31, 2013 Advosory Agreement Two [Member] Spartan Capital Securities, LLC [Member]	Oct. 22, 2013 Advosory Agreement Three [Member]	Dec. 31, 2013 Advosory Agreement Three [Member] Spartan Capital Securities, LLC [Member]	Oct. 22, 2013 Advosory Agreement Three [Member] Spartan Capital Securities, LLC [Member]	Dec. 31, 2013 Year 1 [Member]	Dec. 31, 2013 Year 2 [Member]	Dec. 31, 2013 Year 2 [Member] Maximum [Member]	Dec. 31, 2013 Year 3 [Member]	Dec. 31, 2013 Year 3 [Member] Maximum [Member]	Dec. 31, 2013 Year 4 [Member]
Percentage of royalty rate on net sales												6.00%	4.00%		2.00%		1.00%
Royalty net sales												$ 500,000	$ 500,000	$ 2,500,000	$ 2,500,000	$ 20,000,000	$ 20,000,000
Royalty expenses		203,031	134,121
Proceeds form private placements	5,000,000			6,000,000		5,000,000			2,500,000
Percentage of fee equal to aggregate gross proceeds				10.00%		10.00%		3.00%	10.00%	3.00%
Percentage of common stock issuable				10.00%		10.00%			10.00%
Payment of maximum amount paid for consideration of expenses incurred by Spartan					40,000			10,000		10,000
Spartan fee paid amount					505,400			650,000		104,000
Number of warrants issued		386,666			505,400			333,333		53,333
Warrants Remaining Contractual Life					5 years			5 years		5 years
Warrants exercise price					1.00			1.50			1.50
Spartan advisory agreement description							The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0 mil- $5.0 mil) outlined in the Spartan Advisory Agreement.
Fees cancellation on agreement amendment								$ 10,000

Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details)

Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Agreement Year 1st and 2nd [Member]
Minimum Royalty to be Paid
Agreement Year 3rd and 4th [Member]
Minimum Royalty to be Paid	50,000
Agreement Year 5th, 6th and 7th [Member]
Minimum Royalty to be Paid	75,000
Agreement Year 8th and 9th [Member]
Minimum Royalty to be Paid	100,000
Agreement Year 10th and thereafter [Member]
Minimum Royalty to be Paid	$ 125,000

Income Tax Provision (Benefit) (Details Narrative)

Income Tax Provision (Benefit) (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Valuation allowance	$ 1,306,652	$ 599,149
Domestic Tax Authority [Member]
Net operating loss carryforward	4,600,000	1,600,000
Net operating loss carry-forward expiration date	2033
New Jersey State [Member]
Net operating loss carryforward	$ 4,600,000	$ 1,600,000
Net operating loss carry-forward expiration date	2033

Income Tax Provision (Benefit) - Schedule of Provision for Income Taxes (Details)

Income Tax Provision (Benefit) - Schedule of Provision for Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Federal current
Federal deferred	(945,289)	(599,149)
State and local current
State and local deferred	(361,363)
Change in valuation allowance	1,306,652	599,149
Income tax provision (benefit)

- Definition

Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References+ Details

- Definition

Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References+ Details

- Definition

Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References+ Details

- Definition

Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References+ Details

Income Tax Provision (Benefit) - Schedule of Deferred Tax Assets (Details)

Income Tax Provision (Benefit) - Schedule of Deferred Tax Assets (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Net operating loss carryovers	$ 1,939,069	$ 599,149
Total deferred tax assets	1,939,069	599,149
Valuation allowance	(1,905,801)	(599,149)
Deferred tax asset, net of valuation allowance	33,268
Other deferred tax liabilities	(33,268)
Total deferred tax liabilities	(33,268)
Net deferred tax asset (liability)

Income Tax Provision (Benefit) - Schedule of Effective Income Tax Rate Reconciliation (details)

Income Tax Provision (Benefit) - Schedule of Effective Income Tax Rate Reconciliation (details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
US Federal statutory rate	(34.00%)	(34.00%)
State income tax, net of federal benefit	(5.90%)	(5.90%)
Deferred tax true-up	(6.80%)
Change in valuation allowance	44.30%	36.70%
Other permanent differences	2.40%	3.20%
Income tax provision (benefit)

Subsequent Events (Details Narrative)

Subsequent Events (Details Narrative) (USD $)	6 Months Ended	12 Months Ended		3 Months Ended		0 Months Ended
Subsequent Events (Details Narrative) (USD $)	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Mar. 14, 2014 Subsequent Event [Member]	Mar. 14, 2014 Subsequent Event [Member] Spartan Capital Securities, LLC [Member]	Jan. 03, 2014 Faunus Group International, Inc [Member] Subsequent Event [Member]
Proceeds form private placements	$ 5,000,000					$ 1,500,000
Purchase eligible percentage for account receivable						70.00%
Balance percentage retain to reserve						30.00%
Percentage of purchased accounts allow to advance						70.00%
Per annum interest rate						6.75%
Debt instrument, interest variable rate		1.00%				2.50%
Debt instrument description						Mama’s also agreed to pay to FGI monthly collateral management fees of 0.42% of the average monthly balance of Purchased Accounts. The minimum monthly net funds employed during each contract year hereof shall be $500,000. Additionally, Mama’s paid FGI a one-time facility fee equal to 1% of the FGI Facility upon entry into the Sale and Security Agreement.
Minimum monthly net funds employee agreement						500,000
Common stock issued to investors, shares			5,054,000	536,667
Common stock issued to investors		5,000,000	5,054,000	805,000
Stock issuance cost		$ 1,604,000	$ 1,088,964	$ 104,650
Number of warrants issued		386,666			53,667
Warrants exercise price					1.50